Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | OP-3136 |
Synonyms | |
Therapy Description |
OP-3136 is a selective KAT6 inhibitor, which potentially inhibits tumor cell proliferation and decreases tumor growth (European Journal of Cancer 211 (2024): 114748). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
OP-3136 | OP 3136|OP3136 | OP-3136 is a selective KAT6 inhibitor, which potentially inhibits tumor cell proliferation and decreases tumor growth (European Journal of Cancer 211 (2024): 114748). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06784193 | Phase I | OP-3136 | Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors | Recruiting | USA | AUS | 0 |